Flavonoids as potential inhibitors of SARS-CoV-2 infection: in silico study
https://doi.org/10.20538/1682-0363-2022-1-103-108
Abstract
Background. SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has one of the largest genomes. It encodes 16 non-structural proteins that are necessary for replicating and overcoming host defense mechanisms. Flavonoids are of interest as research objects in developing drugs for comprehensive COVID-19 therapy. This group of compounds is characterized by a wide range of biological activity and a high safety profile.
Aim. To perform virtual screening of flavonoids for possible inhibition of proteins of the SARS-CoV-2 infection.
Materials and methods. Structural proteins of SARS-CoV-2 infection, such as ADP-binding domain NSP3, main protease NSP5, RNA-dependent RNA-polymerase NSP12, and endoribonuclease NSP15, were obtained from Protein Data Bank (PDB). Flavonoid structures were obtained from the ZINC database. Protein models were processed using AutoDockTools software, and ligands were processed in Raccoon | AutoDock VS. Virtual screening and re-docking were performed in AutoDock Vina.
Results. Validation showed agreement between native and re-docked conformations, indicating the applicability of the virtual screening method. Flavonoids interacted with the key amino acid residues in all the studied proteins. The highest binding energy was demonstrated by 3,7-dihydroxyflavone and 6S-coccineone B, the latter having a multimodal effect.
Conclusion. The results of the study may be used for the development of phytomedicines for comprehensive therapy for COVID-19.
Supporting agencies: The study was supported by the “Project for Raising the Competitiveness of the Leading Russian Universities among the World’s Top Research and Education Centers”.
About the Authors
A. Kh. Taldaev
Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
8/2 Trubetskaya Str., Moscow, 119991
R. P. Terekhov
Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
8/2 Trubetskaya Str., Moscow, 119991
I. A. Selivanova
Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
8/2 Trubetskaya Str., Moscow, 119991
References
1. Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17(3):181–192. DOI: 10.1038/s41579-018-0118-9.
2. Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. DOI: 10.1038/s41586-020-2012-7.
3. Ilyasov I.R., Beloborodov V.L., Selivanova I.A. Three ABTS•+ radical cation-based approaches for the evaluation of antioxidant activity: fast- and slow-reacting antioxidant behavior. Chemical Papers. 2018;72:1917–1925. DOI: 10.1007/s11696-018-0415-9.
4. Raj U., Varadwaj P.K. Flavonoids as multi-target inhibitors for proteins associated with ebola virus: in silico discovery using virtual screening and molecular docking studies. Interdiscip. Sci. 2016;8(2):132–141. DOI: 10.1007/s12539-015-0109-8.
5. Плотников М.Б., Тюкавкина Н.А., Плотникова Т.М. Лекарственные препараты на основе диквертина. Томск: Издательство Томского университета, 2005:228.
6. Терехов Р.П., Селиванова И.А. Молекулярное моделирование взаимодействия дигидрокверцетина и его метаболитов с циклооксигеназой-2. Бюллетень сибирской медицины. 2019;18(3):101–106. DOI: 10.20538/1682-0363-2019-3-101–106.
7. Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibilit. J. Comp. Chem. 2009;30(16):2785–2791. DOI: 10.1002/jcc.21256.
8. Kim Y., Jedrzejczak R., Maltseva N.I., Wilamowski M., Endres M., Godzik A. et al. Crystal structure of Nsp15 endoribonuclease NendoUfrom SARS-CoV-2. Protein Sci. 2020;29(7):1596–1605. DOI:10.1002/pro.3873.
9. Forli S., Huey R., Pique M.E., Sanner M.F., Goodsell D.S., Olson A.J. Computational protein–ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 2016;11:905–919. DOI: 10.1038/nprot.2016.051.
10. Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comp. Chem. 2010;31(2):455–461. DOI: 10.1002/jcc.21334.
11. Forni D., Cagliani R., Mozzi A., Pozzoli U., Al-Daghri N., Clerici M. et al. Extensive positive selection drives the evolution of nonstructural proteins in lineage C Betacoronaviruses. J. Virol. 2016;90(7):3627–3639. DOI: 10.1128/JVI.02988-15.
12. Deng X., Hackbart M., Mettelman R.C., O’Brien A., Mielech A.M., Yi G. et al. Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proc. Natl. Acad. Sci. USA. 2017;114(21):4251-4260. DOI: 10.1073/pnas.1618310114.
13. Jin Y., Yang H., Ji W., Wu W., Chen S., Zhang W. et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12(4):372. DOI: 10.3390/v12040372.
Review
For citations:
Taldaev A.Kh., Terekhov R.P., Selivanova I.A. Flavonoids as potential inhibitors of SARS-CoV-2 infection: in silico study. Bulletin of Siberian Medicine. 2022;21(1):103-108. https://doi.org/10.20538/1682-0363-2022-1-103-108
Views:
526
Email this article 